Latent Membrane Protein 2A of Epstein-Barr Virus Binds WW Domain E3 Protein-Ubiquitin Ligases That Ubiquitinate B-Cell Tyrosine Kinases

ABSTRACT The latent membrane protein (LMP) 2A of Epstein-Barr virus (EBV) is implicated in the maintenance of viral latency and appears to function in part by inhibiting B-cell receptor (BCR) signaling. The N-terminal cytoplasmic region of LMP2A has multiple tyrosine residues that upon phosphorylation bind the SH2 domains of the Syk tyrosine kinase and the Src family kinase Lyn. The LMP2A N-terminal region also has two conserved PPPPY motifs. Here we show that the PPPPY motifs of LMP2A bind multiple WW domains of E3 protein-ubiquitin ligases of the Nedd4 family, including AIP4 and KIAA0439, and demonstrate that AIP4 and KIAA0439 form physiological complexes with LMP2A in EBV-positive B cells. In addition to a C2 domain and four WW domains, these proteins have a C-terminal Hect catalytic domain implicated in the ubiquitination of target proteins. LMP2A enhances Lyn and Syk ubiquitination in vivo in a fashion that depends on the activity of Nedd4 family members and correlates with destabilization of the Lyn tyrosine kinase. These results suggest that LMP2A serves as a molecular scaffold to recruit both B-cell tyrosine kinases and C2/WW/Hect domain E3 protein-ubiquitin ligases. This may promote Lyn and Syk ubiquitination in a fashion that contributes to a block in B-cell signaling. LMP2A may potentiate a normal mechanism by which Nedd4 family E3 enzymes regulate B-cell signaling.

[1]  S. Grinstein,et al.  Caffeine and Halothane Sensitivity of Intracellular Ca2+ Release Is Altered by 15 Calcium Release Channel (Ryanodine Receptor) Mutations Associated with Malignant Hyperthermia and/or Central Core Disease* , 1997, The Journal of Biological Chemistry.

[2]  R. Longnecker,et al.  The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. , 2000, Virology.

[3]  Scott A. Peterson,et al.  Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.

[4]  Victor L. J. Tybulewicz,et al.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk , 1995, Nature.

[5]  Christopher A. Ross,et al.  Atrophin-1, the DRPLA Gene Product, Interacts with Two Families of WW Domain-Containing Proteins , 1998, Molecular and Cellular Neuroscience.

[6]  N. Raab-Traub,et al.  Epithelial Cell Adhesion to Extracellular Matrix Proteins Induces Tyrosine Phosphorylation of the Epstein-Barr Virus Latent Membrane Protein 2: a Role for C-Terminal Src Kinase , 1999, Journal of Virology.

[7]  A. DeFranco,et al.  The complexity of signaling pathways activated by the BCR. , 1997, Current opinion in immunology.

[8]  R. Longnecker,et al.  Epstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of EμLMP2A Transgenic Mice , 2000, Journal of Virology.

[9]  M. Perricaudet,et al.  A spliced Epstein‐Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. , 1988, The EMBO journal.

[10]  E. Pirodda,et al.  EBV associated malignancies. , 1987, Journal of experimental pathology.

[11]  P. Leder,et al.  FBP WW domains and the Abl SH3 domain bind to a specific class of proline‐rich ligands , 1997, The EMBO journal.

[12]  H. Yeger,et al.  The C2 Domain of the Ubiquitin Protein Ligase Nedd4 Mediates Ca2+-dependent Plasma Membrane Localization* , 1997, The Journal of Biological Chemistry.

[13]  E. Kieff,et al.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases , 1992, Journal of virology.

[14]  D. Rotin WW (WWP) domains: from structure to function. , 1998, Current topics in microbiology and immunology.

[15]  Martin Scheffner,et al.  Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.

[16]  I. Ernberg,et al.  Epstein-Barr virus: adaptation to a life within the immune system. , 1994, Trends in microbiology.

[17]  A. DeFranco,et al.  Transmembrane signaling by antigen receptors of B and T lymphocytes. , 1995, Current opinion in cell biology.

[18]  M. Saraste,et al.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide , 1996, Nature.

[19]  T Pawson,et al.  Role of Syk in B-cell development and antigen-receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G Waksman,et al.  Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. , 1998, Journal of molecular biology.

[21]  Santhosh K. P. Kumar,et al.  Ubiquitin-mediated degradation of active Src tyrosine kinase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  O. Staub,et al.  WW domains of Nedd4 bind to the proline‐rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. , 1996, The EMBO journal.

[23]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[24]  A. Sparks,et al.  Cloning of ligand targets: Systematic isolation of SH3 domain-containing proteins , 1996, Nature Biotechnology.

[25]  T. Kurosaki,et al.  BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. , 1999, Immunity.

[26]  S. Kumar,et al.  Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.

[27]  A. Sparks,et al.  Identification of Novel Human WW Domain-containing Proteins by Cloning of Ligand Targets* , 1997, The Journal of Biological Chemistry.

[28]  A. Miller,et al.  Improved retroviral vectors for gene transfer and expression. , 1989, BioTechniques.

[29]  D. Choquet,et al.  The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein‐Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. , 1993, The EMBO journal.

[30]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[31]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[32]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule , 1997, The EMBO journal.

[33]  Santhosh K. P. Kumar,et al.  Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Sudol,et al.  Structure and function of the WW domain. , 1996, Progress in biophysics and molecular biology.

[35]  M. Reth Antigen receptor tail clue , 1989, Nature.

[36]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[37]  E. Kieff,et al.  Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. , 1995, Immunity.

[38]  N. Copeland,et al.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice , 1998, Nature Genetics.

[39]  L. Schild,et al.  Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. , 1996, The EMBO journal.

[40]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[41]  M. Reth,et al.  Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus , 1993, Current Biology.

[42]  M. Sudol,et al.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Rickinson,et al.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes , 1992, Journal of virology.

[44]  C. Turck,et al.  BLNK: a central linker protein in B cell activation. , 1998, Immunity.

[45]  Y. Hakak,et al.  Ubiquitin-dependent degradation of active Src , 1999, Current Biology.

[46]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[47]  A. Cheng,et al.  Protein tyrosine kinases in thymocyte development. , 1997, Current opinion in immunology.

[48]  K. Harvey,et al.  Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions. , 1999, Trends in cell biology.

[49]  O. Staub,et al.  Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination , 1997, The EMBO journal.

[50]  R. Longnecker,et al.  Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. , 2000, Journal of virology.

[51]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus interacts with JAK3 and activates STAT proteins , 1999, The EMBO journal.

[52]  Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel , 1994, Cell.

[53]  R. Longnecker,et al.  The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. , 1997, Virology.

[54]  Tony Pawson,et al.  Syk tyrosine kinase required for mouse viability and B-cell development , 1995, Nature.

[55]  E. Kremmer,et al.  Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction , 1996, Journal of virology.

[56]  R. Longnecker,et al.  Regulation of Epstein-Barr virus latency by latent membrane protein 2. , 1996, Trends in microbiology.

[57]  Andrew C. Chan,et al.  BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells , 1999 .

[58]  E. Kremmer,et al.  Tyrosine 112 of Latent Membrane Protein 2A Is Essential for Protein Tyrosine Kinase Loading and Regulation of Epstein-Barr Virus Latency , 1998, Journal of Virology.

[59]  Jaap M Middeldorp,et al.  Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. , 2000, Cancer research.

[60]  D. Rowe,et al.  Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase , 1997, Journal of virology.